| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2006 | WO2005025551A3 Pharmaceutical products comprising bisphosphonates |
| 01/12/2006 | WO2005018574A3 Immunostimulatory combinations and treatments |
| 01/12/2006 | WO2005012270A3 Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same |
| 01/12/2006 | WO2005004817A3 Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases |
| 01/12/2006 | WO2004111199A3 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors |
| 01/12/2006 | WO2004098506A3 Treatment for age-related macular degeneration |
| 01/12/2006 | WO2004090108A3 Irna conjugates |
| 01/12/2006 | WO2004080401A3 Oral insulin therapies and protocol |
| 01/12/2006 | WO2004078130A3 Posh interacting proteins and related methods |
| 01/12/2006 | WO2004075816A3 Method for the production of flavonoid-containing compositions and use thereof |
| 01/12/2006 | WO2004069155A3 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof |
| 01/12/2006 | WO2004063345A3 Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators |
| 01/12/2006 | WO2004062597A3 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 01/12/2006 | WO2004058234A3 Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors |
| 01/12/2006 | WO2004045497A3 Cd26-based therapies for cancers and immune disease |
| 01/12/2006 | WO2003089596A3 Novel prostate tumor-specific promoter |
| 01/12/2006 | US20060009651 Benzophenones as inhibitors of reverse transcriptase |
| 01/12/2006 | US20060009640 Preparation of (-)-galantamine hydrobromide |
| 01/12/2006 | US20060009534 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 01/12/2006 | US20060009533 Asymmetrical hydrogenation of 1-amino-3-(phenyl)-propan-3-one using a catalyst system of rhodium and chiral 4-(dicyclohexyl-phosphino)-2-(diphenylphosphino-methyl)-N-methyl-aminocarbonyl-pyrrolidine on an industrial scale |
| 01/12/2006 | US20060009532 Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards |
| 01/12/2006 | US20060009531 Processes for the preparation of tomoxetine |
| 01/12/2006 | US20060009530 Process for the optical resolution and recycling of tomoxetine |
| 01/12/2006 | US20060009529 Decyclization of a pyrrolo[1,2-a]pyrazino or pyrrolo[1,2-c]morpholino dione to a carboxylic acid, amidation with a substituted aniline, coupling and etherification with a phenol or amination with an aniline; hormone replacement therapies, bone and metabolic disorders, anticarcinogenic agents |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009524 Methods for producing D-beta-hydroxyamino acids |
| 01/12/2006 | US20060009523 High concentration baclofen preparations |
| 01/12/2006 | US20060009522 Compositions and methods for treating eye disorders and conditions |
| 01/12/2006 | US20060009521 Lipoxin analogs as novel inhibitors of angiogenesis |
| 01/12/2006 | US20060009520 Retinoid-based methods for altering macrophage cholesterol |
| 01/12/2006 | US20060009518 Constrained cyano compounds |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | US20060009516 Use of ingap for reversing diabetes |
| 01/12/2006 | US20060009515 Process and intermediates for preparing escitalopram |
| 01/12/2006 | US20060009514 Method for treating obesity |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009512 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/12/2006 | US20060009510 Method of synthesizing indolinone compounds |
| 01/12/2006 | US20060009509 Progesterone receptor antagonists, contraceptive regimens, and kits |
| 01/12/2006 | US20060009508 5-alkyl-2-thia-5-azabicyclo[2.2.1]heptan-3-ones or salts thereof which are useful as synthetic intermediates |
| 01/12/2006 | US20060009507 LPA receptor agonists and antagonists and methods of use |
| 01/12/2006 | US20060009506 Drugs for the treatment of neoplastic disorders |
| 01/12/2006 | US20060009505 Anti-cancer composition comprising DMXAA or related compound |
| 01/12/2006 | US20060009504 Pharmaceutical compositions |
| 01/12/2006 | US20060009503 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 01/12/2006 | US20060009502 Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| 01/12/2006 | US20060009501 Materials and methods for immune system stimulation |
| 01/12/2006 | US20060009500 Antiproliferative 1,2,3-thiadiazole compounds |
| 01/12/2006 | US20060009499 Compositions useful for the treatment of follicular diseases |
| 01/12/2006 | US20060009498 Ophthalmic compositions and methods for treating ophthalmic conditions |
| 01/12/2006 | US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/12/2006 | US20060009496 Method for preventing hemoprotein and heme-mediated lipid peroxidation |
| 01/12/2006 | US20060009495 Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/12/2006 | US20060009494 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 01/12/2006 | US20060009493 Indolinone hydrazides as c-Met inhibitors |
| 01/12/2006 | US20060009492 Cancer treatment with compounds inhibiting PKC alpha |
| 01/12/2006 | US20060009491 Amido compounds and their use as pharmaceuticals |
| 01/12/2006 | US20060009490 Enantiomerically pure atomoxetine and tomoxetine mandelate |
| 01/12/2006 | US20060009489 Prepared from racemic tomoxetine; also provides enantiomerically pure atomoxetine HCl prepared from (R)-(-)-tomoxetine (S)-(+)-mandelate; selective norepinephrine reuptake inhibitor; high enantiomeric purity, efficiency; Attention-Deficit/Hyperactivity Disorder (ADHD) |
| 01/12/2006 | US20060009488 Prodrugs of selective androgen receptor modulators and methods of use thereof |
| 01/12/2006 | US20060009487 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 01/12/2006 | US20060009486 Composition and method for treatment and prevention of coronary artery disease |
| 01/12/2006 | US20060009485 Method of reprocessing quaternary ammonium-containing neuromuscular blocking agents |
| 01/12/2006 | US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/12/2006 | US20060009483 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009481 Arylindenopyridines and related therapeutic and prophylactic methods |
| 01/12/2006 | US20060009480 Sinomenine and sinomenine compounds, synthesis and use |
| 01/12/2006 | US20060009479 Process for the synthesis of hydromorphone |
| 01/12/2006 | US20060009478 Methods for the treatment of back pain |
| 01/12/2006 | US20060009477 pyridine or pyrimidine thieno(2,3-e) pyrimidine tricyclic compounds; metabotropic glutamate receptor antagonist; analgesic, anxiolytic agent: pain, migraine, urinary incontinence; neurodegenerative diseases: Alzheimer's disease |
| 01/12/2006 | US20060009476 Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof |
| 01/12/2006 | US20060009475 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 01/12/2006 | US20060009474 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 01/12/2006 | US20060009473 Formulations of 6-mercaptopurine |
| 01/12/2006 | US20060009472 Substituted imidazole derivatives |
| 01/12/2006 | US20060009471 Amido compounds and their use as pharmaceuticals |
| 01/12/2006 | US20060009470 Method for specifically potentiating N-type Ca2+ channel activity |
| 01/12/2006 | US20060009469 Particulate-stabilized injectable pharmacutical compositions of posaconazole |
| 01/12/2006 | US20060009468 Method for treatment of cancer |
| 01/12/2006 | US20060009467 Novel gamma secretase inhibitors |
| 01/12/2006 | US20060009466 Headwear having linear design |
| 01/12/2006 | US20060009465 Treatment of sleep disorders using sleep target modulators |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009463 N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis |
| 01/12/2006 | US20060009462 Prodrugs of CC-1065 analogs |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009460 e.g. N-(4-(4-methylpiperazin-1-yl)phenyl)-6-phenylquinolin-4-amine;protein kinase A, C, G, tyrosine kinase, mitogen activated p38- alpha kinase inhibitor; tumor necrosis factor- alpha and interleukin-1 beta antagonist; antiinflammatory, anticarcinogenic; Alzheimer's disease, stroke, diabetes, obesity |
| 01/12/2006 | US20060009459 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders |
| 01/12/2006 | US20060009458 Prophylactic or therapeutic agents for diseases associated with dysfunction of NOS |
| 01/12/2006 | US20060009457 New pyridodihydropyrazinones, process for their manufacture and use thereof as medicaments |
| 01/12/2006 | US20060009456 Aryl-substituted piperazine derivatives |
| 01/12/2006 | US20060009455 especially blood coagulation factor XIa and plasma kallikrein; e.g. 4-aminomethyl-[2-phenyl-1-(4-phenyl-pyridin-2-yl)-ethyl]-trans cyclohexanecarboxamide; anticoagulant, antiinflammatory agent; |
| 01/12/2006 | US20060009454 Pyrrolotriazine kinase inhibitors |
| 01/12/2006 | US20060009453 Protein kinase modulators and method of use |
| 01/12/2006 | US20060009452 Therapeutic targeting of PARC/CCL18 and its signaling in pulmonary fibrosis |